Prof Adam Fox | GMC# 4312583

  • Guy's & St Thomas' Hospitals NHS Foundation Trust
  • Consultant Paediatric Allergist & Deputy Medical Director

Declaration History

2020

Declaration April 20, 2020, 6:43 p.m.

Clinical Positions

  • NHS : Guy's & St Thomas' Hospitals NHS Foundation Trust Consultant Paediatric Allergist / Deputy Medical Director

Consultancy £100- £1000

MHRA Expert Working Group on Adrenaline Auto-injectors

Academic

Other work £100- £1000

ITV 'This Morning'

Financial

Spousal

Sponsored

Political


Something wrong with this declaration? Contact team@sunshineuk.org to let them know.

Declaration Jan. 12, 2020, 10:09 p.m.

Clinical Positions

  • NHS : Guy's & St Thomas' Hospitals NHS Foundation Trust Consultant Paediatric Allergist / Deputy Medical Director

Consultancy £2000 - £5000

HM Coroner's court - Expert witness work in relation to inquest, November 2019. I have consulted for companies (DBV technologies, Stallergenes) on behalf of my NHS trust, as part of my regular NHS employment. No personal fees received.

Academic

Previous studies with ALK-Abello or Danone, ended in 2019.

Other work

President of BSACI, unpaid. BSACI receives industry sponsorship, please see bsaci.org. Chair of Allergy UK health advisory board, unpaid. Allergy UK receives industry sponsorship, please see allergyuk.org. Member of National Allergy Strategy Group. NASG receives industry sponsorship, please see nasguk.org. Advisor to charities including Anaphylaxis Campaign, unpaid. Governor, North London Collegiate School, unpaid.

Financial under £100

HCA Waterfront, Elstree. Investor (2.5% equity). 50% owner of Allergy London ltd (Private practice)

Spousal

Sponsored

Travel, registration & attendance at EAACI conference, Lisbon as speaker. Travel, registration & attendance at BSACI conference, Harrogate as session chair. Travel and speaker fee for lecture at National Immunisation Conference, Manchester.

Political


Something wrong with this declaration? Contact team@sunshineuk.org to let them know.

Archived Declarations


Feb. 26, 2019

Benefits received from pharmaceutical companies


Company Reason for receipt of fees Total amount received
DBV laboratories Consultancy relating to peanut epicutaneous desensitization & lecture Sept 2018. 3
Aimmune Consultancy relating to peanut oral desensitisation. 3

Other sources of income or benefits from other organisations relevant to medical practice


Company Reason for receipt of fees Total amount received
KCL Allergy Academy Director. NHS salary recharge for 1 PA. Academy supported by multiple industry sponsors - see allergyacademy.org £5000 - £10000
University College Cork External Examiner for Undergraduate Paediatrics 2
Metropolitan Police Expert witness for coroner’s inquest 3

Fees directly received from other medical companies


Company Reason for receipt of fees Total amount received
HCA Waterfront Elstree Investor (2.5% equity) under £100

Research grants paid by private institutions to your department


Company Reason for receipt of fees Total amount received
ALK-Abello MT-11 study - Institutional Funding for Commercial Research (including part contribution to NHS salary recharge for 1 research PA) £5000 - £10000
Danone PRESTO study - Institutional Funding for Commercial Research (including part contribution to NHS salary recharge for 1 research PA) £5000 - £10000

Past Declarations


This section relates to activity since the last declaration in July 2018


Other Declarations


Stallergenes Greer - Consultancy relating to sublingual immunotherapy done on behalf of NHS trust. No personal payment.

President of BSACI, unpaid. BSACI receives industry sponsorship, please see bsaci.org. Trustee of Allergy UK (& Chair of health advisory board), unpaid. Allergy UK receives industry sponsorship, please see allergyuk.org. Advisor to charities including Anaphylaxis Campaign, Living with Reflux, FABED (Families living with Eosinophilic Disorders), unpaid. Governor, North London Collegiate School, unpaid. Lecture given at Sharjah University Hospital Annual Paediatric Conference, Dubai, February 2019. No payment but flight and accommodation paid for by event organiser.


July 25, 2018

Benefits received from pharmaceutical companies


Company Reason for receipt of fees Total amount received
Danone Advisory Boards, Lecturing & medical writing £10000 - £50 000
Stallergenes Greer Lecturing 4
DBV technologies Advisory Boards & Lecturing 3
Nestle Nutrition Medical writing 3
Mead Johnson Advisory Boards, Lecturing £5000 - £10000
Aimmune Consultancy on market access £5000 - £10000

Other sources of income or benefits from other organisations relevant to medical practice


Company Reason for receipt of fees Total amount received
KCL Allergy Academy Director. NHS salary recharge for 1 PA (approx. £10,000 annually). Academy supported by multiple industry sponsors. £5000 - £10000
F2F Events Clinical Director of CPD Event for Allergy & Free From Show 4

Fees directly received from other medical companies


Company Reason for receipt of fees Total amount received
HCA Elstree Investor (2.5% equity) under £100

Research grants paid by private institutions to your department


Company Reason for receipt of fees Total amount received
Danone Institutional Funding for Commercial Research including part contribution to NHS salary recharge for 1 PA (approx. £10,000 annually) 4
ALK-Abello Institutional Funding for Commercial Research including part contribution to NHS salary recharge for 1 PA (approx. £10,000 annually) 4

Other Declarations


BSACI - President (from Oct 2018), No payment Allergy UK Trustee & Chair of Health Advisory Board, No payment